Embracing Pathology's Digital Transformation
Expert pathologists from Europe, Japan and the United States share their insights on how to embrace digital pathology and prepare labs for AI.
Learning Objectives
- Learn how digital pathology can address future demands
- Explore how AI can meet pathologists' needs
- Gain perspective on Global lab readiness for AI
- Become a champion of DP/AI in your lab
Hosted by Colin White, Leica Biosystems’ SVP and General Manager, Advanced Staining & Imaging, three global pathologists share their thoughts as to how digital pathology can address future demands and enable AI to meet pathologists’ needs.
About the presenters
Dr. Catarina Eloy is the Head of the Pathology Laboratory of IPATIMUP/ Researcher at i3S/ Affiliated Professor of Medical Faculty of The University of Porto. She is also the former President of the European Society for Digital and Integrative Pathology and Vice-president of the Portuguese Society of Anatomic Pathology.
Dr. Eloy received her MD in 2003 from the Medical Faculty of The University of Porto with a specialization in Pathology
Dr. Eloy has been a researcher since 2006 at the cancer signaling & metabolism of i3S/Ipatimup and received a Ph.D. in Thyroid cancer in 2012 by the Medical Faculty of The University of Porto.
Dr. Eloy has 70 publications and three academic and scientific awards/distinctions.
Prof. Jun Fukuoka is a Japanese pathologist whose expertise lies in the field of pulmonary disease and digital pathology. He has graduated from Shiga University of Medical Science in 1995 and studied lung pathology and molecular research at Mayo Clinic, AFIP, and NIH.
He was promoted to full professor in 2009 in Toyama University and relocated as a department chair and professor at Nagasaki University in 2012. From 2017, he started cross-appointment with one of the largest hospitals, Kameda Medical Center, Department of Pathology, in Japan. He allocates 60% of his time at Nagasaki University and 40% at Kameda Medical Center.
He has launched two start-up companies during his career in the field of pathology. He is also a good teacher and has developed more than 30 pathologists worldwide and has mentored more than 100 undergraduate students/residents on either presenting research works in international meetings or publishing in scientific journals.
He has started research in digital pathology since 2010 and has developed a fully digitized network to share diagnostic process and education among several large institutes. Through the network, virtual large laboratory among several institutes has been created. His young team is enthusiastic to develop the workflow of human-AI collaboration.
He currently serves as Vice-President at Japanese Society of Digital Pathology (JSDP) and Treasurer of Digital Pathology Association (DPA).
Dr. Anil Parwani is a Professor of Pathology at The Ohio State University. He serves as the Vice Chair and Director of Anatomical Pathology. Dr. Parwani is also the Director of Pathology Informatics and Director of the Digital Pathology Shared Resource at The James Cancer Hospital.
His research is focused on diagnostic and prognostic markers in bladder and prostate cancer, and molecular classification of renal cell carcinoma. Dr. Parwani has expertise in the area of Anatomical Pathology Informatics including designing quality assurance tools, bio banking informatics, clinical and research data integration, applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation.
Dr. Parwani has authored over 250 peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and one of the Editors of the Journal of Pathology Informatics.
Colin White is an IVD industry veteran with more than 20 years of experience in conceiving, developing and commercializing systems that advance the practice of pathology.
Prior to his retirement in 2023, Colin was the Senior Vice President and General Manager, Advanced Staining & Imaging at Leica Biosystems, a position he held since 2015. Colin’s passion is innovation and motivating teams to develop solutions that advance patient care whilst also meeting the needs of healthcare providers and regulating bodies.
Early in his career, Colin spent about a decade with BHP, a global resources company. Colin has a PhD and bachelor’s degree in chemical engineering from Monash University in Melbourne, Australia.
Die Inhalte des Knowledge Pathway von Leica Biosystems unterliegen den Nutzungsbedingungen der Website von Leica Biosystems, die hier eingesehen werden können: Rechtlicher Hinweis. Der Inhalt, einschließlich der Webinare, Schulungspräsentationen und ähnlicher Materialien, soll allgemeine Informationen zu bestimmten Themen liefern, die für medizinische Fachkräfte von Interesse sind. Er soll explizit nicht der medizinischen, behördlichen oder rechtlichen Beratung dienen und kann diese auch nicht ersetzen. Die Ansichten und Meinungen, die in Inhalten Dritter zum Ausdruck gebracht werden, spiegeln die persönlichen Auffassungen der Sprecher/Autoren wider und decken sich nicht notwendigerweise mit denen von Leica Biosystems, seinen Mitarbeitern oder Vertretern. Jegliche in den Inhalten enthaltene Links, die auf Quellen oder Inhalte Dritter verweisen, werden lediglich aus Gründen Ihrer Annehmlichkeit zur Verfügung gestellt.
Vor dem Gebrauch sollten die Produktinformationen, Beilagen und Bedienungsanleitungen der jeweiligen Medikamente und Geräte konsultiert werden.
Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.